Considering the societal perspective in economic evaluations: a systematic review in the case of depression
Open accessAbstract
Background: Depressive disorders are associated with a high burden of disease. However, due to the burden posed by the disease on not only the sufferers, but also on their relatives, there is an ongoing debate about which costs to include and, hence, which perspective should be applied. Therefore, the aim of this paper was to examine whether the change between healthcare payer and societal perspective leads to different conclusions of cost-utility analyses in the case of depression. Methods: A systematic literature search was conducted to identify economic evaluations of interventions in depression, launched on Medline and the Cost-Effectiveness Registry of the Tufts University using a ten-year time horizon (2008–2018). In a two-stepped screening process, cost-utility studies were selected by means of specified inclusion and exclusion criteria. Subsequently, relevant findings was extracted and, if not fully stated, calculated by the authors of this work. Results: Overall, 53 articles with 92 complete economic evaluations, reporting costs from healthcare payer/provider and societal perspective, were identified. More precisely, 22 estimations (24%) changed their results regarding the cost-effectiveness quadrant when the societal perspective was included. Furthermore, 5% of the ICURs resulted in cost-effectiveness regarding the chosen threshold (2% of them became dominant) when societal costs were included. However, another four estimations (4%) showed the opposite result: these interventions were no longer cost-effective after the inclusion of societal costs. Conclusions: Summarising the disparities in results and applied methods, the results show that societal costs might alter the conclusions in cost-utility analyses. Hence, the relevance of the perspectives chosen should be taken into account when carrying out an economic evaluation. This systematic review demonstrates that the results of economic evaluations can be affected by different methods available for estimating non-healthcare costs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
YAM was compared to gatekeeper training in a randomized trial and found to be more effective.
“YAM was compared to gatekeeper training in a randomized trial and found to be more effective. 383”
From Time for united action on depression: a Lancet–World Psychiatric Association Commission (2022) · cites this paper as [383]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867 · see citing works
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648 · see citing works
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220 · see citing works
Methods for the economic evaluation of health care programmes
Wilson, S. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,312 · see citing works
National trends in the prevalence and treatment of depression in adolescents and young adults.
Mojtabai, R., Olfson, M., & Han, B. (2016) · Pediatrics · doi:10.1542/peds.2016-1878 · Cited by 1,424 · see citing works
Social determinants of mental health
Allen, J., Balfour, R., Bell, R., & Marmot, M. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2014.928270 · Cited by 1,411 · see citing works
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,103 · see citing works
Evers, S., Goossens, M. E. J. B., de Vet, H. C. W., van Tulder, M. W., & Ament, A. J. H. A. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050324 · Cited by 860 · see citing works
Trautmann, S., Rehm, J., & Wittchen, H. (2016) · The EMBO Reports · doi:10.15252/embr.201642951 · Cited by 798 · see citing works
Sobocki, P., Jönsson, B., Angst, J., & Rehnberg, C. (2006) · PubMed · Cited by 533 · see citing works
What Does Research Tell Us About Depression, Job Performance, and Work Productivity?
Lerner, D., & Henke, R. M. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31816bae50 · Cited by 510 · see citing works
Patel, V., Weobong, B., Weiss, H. A., Anand, A., Bhat, B., Katti, B., Dimidjian, S., Araya, R., Hollon, S. D., King, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31589-6 · Cited by 448 · see citing works
Briggs, A. H., OʼBrien, B. J., & Blackhouse, G. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140534 · Cited by 404 · see citing works
Evans-Lacko, S., & Knapp, M. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1278-4 · Cited by 390 · see citing works
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-11-6 · Cited by 381 · see citing works
Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337 · see citing works
The Social Determinants of Mental Health
Sederer, L. I. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201500232 · Cited by 264 · see citing works
The economic impact of mental health stigma and discrimination: A systematic review
Sharac, J., McCrone, P., Clement, S., & Thornicroft, G. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001159 · Cited by 262 · see citing works
Mental Disorders Top The List Of The Most Costly Conditions In The United States: $201 Billion
Roehrig, C. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1659 · Cited by 246 · see citing works
Banerjee, S., Hellier, J. M., Romeo, R., Dewey, M. E., Knapp, M. R. J., Ballard, C. G., Baldwin, R., Bentham, P., Fox, C., Holmes, C., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17070 · Cited by 233 · see citing works
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
Khoo, A. L., Zhou, H. J., Teng, M., Lin, L., Zhao, Y. J., Soh, L. B., Mok, Y. M., Lim, B. P., & Gwee, K. P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0267-6 · Cited by 230 · see citing works
Prevalence and Predictors of Depression Treatment in an International Primary Care Study
Simon, G. E., Fleck, M. P. D. A., Lucas, R., Bushnell, D. M., & LIDO Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1626 · Cited by 218 · see citing works
Stigma and depression among primary care patients
Roeloffs, C., Sherbourne, C., Unützer, J., Fink, A., Tang, L., & Wells, K. B. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(03)00066-5 · Cited by 208 · see citing works
Common methodological flaws in economic evaluations
Drummond, M., & Sculpher, M. (2005) · Medical Care · doi:10.1097/01.mlr.0000170001.10393.b7 · Cited by 204 · see citing works
How to Include Informal Care in Economic Evaluations
Hoefman, R., van Exel, J. N. A., & Brouwer, W. B. F. (2013) · PharmacoEconomics · doi:10.1007/s40273-013-0104-z · Cited by 170 · see citing works
Is the EQ–5D fit for purpose in mental health?
Brazier, J. E. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.082453 · Cited by 167 · see citing works
Warmerdam, L., Smit, F., van Straten, A., Riper, H., & Cuijpers, P. (2010) · Journal of Medical Internet Research · doi:10.2196/jmir.1436 · Cited by 158 · see citing works
Krol, M., Papenburg, J., & van Exel, J. N. A. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0218-y · Cited by 157 · see citing works
The Inclusion of Informal Care in Applied Economic Evaluation: A Review
Goodrich, K., Kaambwa, B., & Al‐Janabi, H. (2012) · Value in Health · doi:10.1016/j.jval.2012.05.009 · Cited by 140 · see citing works
Gerhards, S. A. H., de Graaf, L. E., Jacobs, L. E., Severens, J. L., Huibers, M. J. H., Arntz, A., Riper, H., Widdershoven, G., Metsemakers, J. F. M., & Evers, S. M. A. A. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.065748 · Cited by 135 · see citing works
Weobong, B., Weiss, H. A., McDaid, D., Singla, D. R., Hollon, S. D., Nadkarni, A., Park, A.-L., Bhat, B., Katti, B., Anand, A., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002385 · Cited by 135 · see citing works
Wiles, N., Thomas, L., Abel, A., Barnes, M., Carroll, F., Ridgway, N., Sherlock, S., Turner, N., Button, K., Odondi, L., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18310 · Cited by 127 · see citing works
Hollinghurst, S., Peters, T. J., Kaur, S., Wiles, N., Lewisand, G., & Kessler, D. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.073080 · Cited by 123 · see citing works
The Limitations of QALY: A Literature Review
Pettitt, D. A., & Raza, S. (2016) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000334 · Cited by 110 · see citing works
The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care
Ekman, M., Granström, O., Omérov, S., Jacob, J., & Landén, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.003 · Cited by 101 · see citing works
Simpson, K. N., Welch, M. J., Kozel, F. A., Demitrack, M. A., & Nahas, Z. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0013-x · Cited by 90 · see citing works
Kuyken, W., Hayes, R. A., Barrett, B. M., Byng, R., Dalgleish, T., Kessler, D. S., Lewis, G., Watkins, E. R., Morant, N. J., Taylor, R. S., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19730 · Cited by 81 · see citing works
Buntrock, C., Berking, M., Smit, F., Lehr, D., Nobis, S., Riper, H. M., Cuijpers, P. J., & Ebert, D. D. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6587 · Cited by 78 · see citing works
Romero-Sanchiz, P., Nogueira-Arjona, R., García-Ruiz, A., Luciano, J. V., García Campayo, J., Gili, M., Botella, C., Baños, R., Castro, A., López-Del-Hoyo, Y., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172741 · Cited by 78 · see citing works
CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW
Drost, R. M. W. A., van der Putten, I. M., Ruwaard, D., Evers, S., & Paulus, A. T. G. (2017) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462317000526 · Cited by 77 · see citing works
Patient-reported Depression Severity Measured by the PHQ-9 and Impact on Work Productivity
Jain, G., Roy, A. N., Harikrishnan, V., Yu, S. S., Dabbous, O. H., & Lawrence, C. (2013) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31828349c9 · Cited by 75 · see citing works
Kohls, E., Coppens, E., Hug, J., Wittevrongel, E., Audenhove, C. V., Koburger, N., Arensman, E., Székely, A., Gusmão, R. M., & Hegerl, U. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.006 · Cited by 74 · see citing works
The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra
Brouwer, W. B. F. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0730-6 · Cited by 73 · see citing works
Grosse, S. D., Pike, J. J., Soelaeman, R. H., & Tilford, J. M. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00782-9 · Cited by 73 · see citing works
Chalder, M., Wiles, N., Campbell, J., Hollinghurst, S., Searle, A., Haase, A., Taylor, A., Fox, K., Baxter, H., Davis, M., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16100 · Cited by 71 · see citing works
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions
Lin, P., D’Cruz, B. N., Leech, A. A., Neumann, P. J., Aigbogun, M. S., Oberdhan, D., & Lavelle, T. A. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00788-3 · Cited by 69 · see citing works
Evaluating the economic impact of screening and treatment for depression in the workplace
Evans-Lacko, S. E., Koeser, L., Knapp, M. R. J., Longhitano, C., Zohar, J., & Kuhn, K. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.005 · Cited by 64 · see citing works
Cost of depression: effect of adherence and treatment response
von Knorring, L., Åkerblad, A.-C., Bengtsson, F., Carlsson, Å., & Ekselius, L. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.04.005 · Cited by 58 · see citing works
Ramsberg, J., Asseburg, C., & Henriksson, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042003 · Cited by 57 · see citing works
Transferability indices for health economic evaluations: methods and applications
Antoñanzas, F., Rodríguez‐Ibeas, R., Juárez-Castelló, C. A., Hutter, F., Lorente, R., & Pinillos, M. (2008) · Health Economics · doi:10.1002/hec.1397 · Cited by 53 · see citing works
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
Romeo, R., Knapp, M. R. J., Hellier, J. M., Dewey, M. E., Ballard, C. G., Baldwin, R., Bentham, P., Burns, A. S., Fox, C., Holmes, C., et al. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.115212 · Cited by 53 · see citing works
Green, C., Richards, D. A., Hill, J. J., Gask, L., Lovell, K., Chew-Graham, C., Bower, P., Cape, J., Pilling, S., Araya, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104225 · Cited by 52 · see citing works
Richards, D., Bower, P., Chew-Graham, C., Gask, L., Lovell, K., Cape, J., Pilling, S., Araya, R., Kessler, D., Barkham, M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20140 · Cited by 52 · see citing works
Krol, M., Papenburg, J., Tan, S. S., Brouwer, W. B. F., & Roijen, L. H. (2015) · The European Journal of Health Economics · doi:10.1007/s10198-015-0685-x · Cited by 52 · see citing works
Richards, D. A., Rhodes, S., Ekers, D., McMillan, D., Taylor, R. S., Byford, S., Barrett, B. M., Finning, K., Ganguli, P., Warren, F. C., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21460 · Cited by 51 · see citing works
Hornberger, J. M., Li, Q., & Quinn, B. (2015) · PubMed · Cited by 50 · see citing works
Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder
Groessl, E. J., Tally, S. R., Hillery, N., Maciel, A., & Garces, J. A. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.8.726 · Cited by 48 · see citing works
Simons, C. J. P., Drukker, M., Evers, S., van Mastrigt, G. A. P. G., Höhn, P., Kramer, I., Peeters, F. P. M. L., Delespaul, P., Menne‐Lothmann, C., Hartmann, J., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1577-7 · Cited by 40 · see citing works
van der Aa, H. P. A., van Rens, G. H. M. B., Bosmans, J. E., Comijs, H. C., & van Nispen, R. M. A. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1437-5 · Cited by 39 · see citing works
Saret, C. J., Winn, A. N., Shah, G. L., Parsons, S. K., Lin, P., Cohen, J. T., & Neumann, P. J. (2015) · Blood · doi:10.1182/blood-2014-07-592832 · Cited by 39 · see citing works
Depression in Working Adults: Comparing the Costs and Health Outcomes of Working When Ill
Cocker, F., Nicholson, J. M., Graves, N., Oldenburg, B. F., Palmer, A. J., Martin, A. J., Scott, J. L., Venn, A., & Sanderson, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105430 · Cited by 39 · see citing works
Vasiliadis, H., Dezetter, A., Latimer, E. A., Drapeau, M., & LESAGE, A. D. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600395 · Cited by 39 · see citing works
Messori, A., & Trippoli, S. (2017) · Heart · doi:10.1136/heartjnl-2017-311816 · Cited by 39 · see citing works
The economic impact of initiatives to reduce stigma: demonstration of a modelling approach
McCrone, P., Knapp, M., Henri, M., & McDaid, D. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x0000083x · Cited by 36 · see citing works
Hollinghurst, S., Carroll, F. E., Abel, A., Campbell, J., Garland, A., Jerrom, B., Kessler, D., Kuyken, W., Morrison, J., Ridgway, N., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.125286 · Cited by 36 · see citing works
Joling, K. J., Bosmans, J. E., van Marwijk, H., van der Horst, H. E., Scheltens, P., Vroomen, J. L. M., & van Hout, H. P. J. (2013) · Trials · doi:10.1186/1745-6215-14-305 · Cited by 36 · see citing works
Rubio-Valera, M., Bosmans, J. E., Fernández, A., Peñarrubia-María, M., March, M., Travé, P., Bellón, J. Á., & Serrano‐Blanco, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070588 · Cited by 35 · see citing works
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT
Kessler, D. S., Burns, A., Tallon, D., Lewis, G., MacNeill, S., Round, J. A., Hollingworth, W., Chew-Graham, C. A., Anderson, I. M., Campbell, J., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22630 · Cited by 34 · see citing works
How relevant are social costs in economic evaluations? The case of Alzheimer’s disease
Peña-Longobardo, L. M., Rodríguez-Sánchez, B., Oliva-Moreno, J., Aranda-Reneo, I., & López‐Bastida, J. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01087-6 · Cited by 33 · see citing works
Self-citationDixon, P., Hollinghurst, S., Edwards, L., Thomas, C., Foster, A., Davies, B., Gaunt, D., Montgomery, A. A., & Salisbury, C. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.116.002907 · Cited by 30 · see citing works
Kolovos, S., Kenter, R. M. F., Bosmans, J. E., Beekman, A. T. F., Cuijpers, P. J., Kok, R. N., & van Straten, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.025 · Cited by 29 · see citing works
Eveleigh, R., Grutters, J., Muskens, E., Oude Voshaar, R., van Weel, C., Speckens, A., & Lucassen, P. (2014) · Family Practice · doi:10.1093/fampra/cmu043 · Cited by 28 · see citing works
Fernández, A., Mendive, J. M., Cerón, S. C., Moreno-Peral, P., King, M., Nazareth, I., Martín-Pérez, C., Fernández-Alonso, C., Rodríguez-Bayón, A., Aiarzagüena, J. M., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1005-y · Cited by 28 · see citing works
Hounton, S., & Newlands, D. (2012) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-10-8 · Cited by 27 · see citing works
Sado, M., Knapp, M. R. J., Yamauchi, K., Fujisawa, D., So, M., Nakagawa, A., Kikuchi, T., & Ono, Y. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902873664 · Cited by 27 · see citing works
Cost-utility of collaborative care for major depressive disorder in primary care in the Netherlands
Goorden, M., Huijbregts, K. M. L., van Marwijk, H. W. J., Beekman, A. T. F., van der Feltz-Cornelis, C. M., & Hakkaart-van Roijen, L. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.06.006 · Cited by 26 · see citing works
Goorden, M., Vlasveld, M. C., Anema, J. R., van Mechelen, W., Beekman, A. T. F., Hoedeman, R., Feltz-Cornelis, C. M. V. D., & Roijen, L. H. (2013) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-013-9483-4 · Cited by 26 · see citing works
Bosmans, J. E., Hermens, M. L., de Bruijne, M. C., van Hout, H. P. J., Terluin, B., Bouter, L. M., Stalman, W. A. B., & van Tulder, M. W. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.02.002 · Cited by 24 · see citing works
Annemans, L., Brignone, M., Druais, S., Pauw, A. D., Gauthier, A., & Demyttenaere, K. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0138-x · Cited by 23 · see citing works
Cost-effectiveness analysis of a collaborative care programme for depression in primary care
Aragonès, E., López-Cortacans, G., Sánchez, E., Piñol, J. L., Caballero, A., Salvador‐Carulla, L., & Hita, J. M. C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.021 · Cited by 23 · see citing works
van Eeden, M., Kootker, J. A., Evers, S., Heugten, C. M. V., Geurts, A. C. H., & van Mastrigt, G. A. P. G. (2015) · BMC Neurology · doi:10.1186/s12883-015-0522-y · Cited by 23 · see citing works
Cost–effectiveness of preventive interventions for depressive disorders: an overview
Mihalopoulos, C., & Vos, T. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.13.5 · Cited by 22 · see citing works
REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE
Mandrik, O., Knies, S., Kaló, Z., & Severens, J. L. (2015) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462315000677 · Cited by 22 · see citing works
The Social Cost of Major Depression. A Systematic Review
Coretti, S., Rumi, F., & Cicchetti, A. (2019) · Review of European Studies · doi:10.5539/res.v11n1p73 · Cited by 22 · see citing works
Ekman, M., Lindgren, P., Miltenburger, C., Meier, G., Locklear, J. C., & Chatterton, M. L. (2012) · PharmacoEconomics · doi:10.2165/11594930-000000000-00000 · Cited by 21 · see citing works
Cost-effectiveness of depression case management in small practices
Gensichen, J. S., Petersen, J. J., Korff, M. V., Heider, D., Baron, S., König, J., Freytag, A., Krauth, C., Gerlach, F. M., & König, H. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.118257 · Cited by 21 · see citing works
Soini, E. J., Hallinen, T., Brignone, M., Campbell, R., Diamand, F., Cure, S., Aalto-Setälä, M., Danchenko, N., Koponen, H., & Kolasa, K. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1240617 · Cited by 20 · see citing works
Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
Snedecor, S. J., Botteman, M. F., Schaefer, K., Sarocco, P. W., Barry, N., & Pickard, A. S. (2010) · PubMed · Cited by 19 · see citing works
Maniadakis, N., Kourlaba, G., Mougiakos, T., Chatzimanolis, I., & Jönsson, L. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-173 · Cited by 17 · see citing works
Vataire, A. L., Aballéa, S., Antoñanzas, F., Roijen, L. H., Lam, R. W. M., McCrone, P., Persson, U., & Toumi, M. (2014) · Value in Health · doi:10.1016/j.jval.2013.11.012 · Cited by 15 · see citing works
Choi, S.-E., Brignone, M., Cho, S. J., Jeon, H. J., Jung, R., Campbell, R., François, C., & Milea, D. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1128830 · Cited by 14 · see citing works
(2009) · PubMed · Cited by 12 · see citing works
Nordstrom, G., Danchenko, N., Despiégel, N., & Marteau, F. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.011 · Cited by 11 · see citing works
Meuldijk, D., Carlier, I. V. E., van Vliet, I. M., van Hemert, A. M., Zitman, F. G., & Marle, M. E. V. D. A. (2015) · PubMed · Cited by 11 · see citing works
Brettschneider, C., Kohlmann, S., Gierk, B., Löwe, B., & König, H.-H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181021 · Cited by 11 · see citing works
Fluoxetine and imipramine: are there differences in cost‐utility for depression in primary care?
Serrano‐Blanco, A., Suarez, D. L., Pinto‐Meza, A., Peñarrubia‐María, M. T., Haro, J. M., & DAPGA Group (Depressió en Atenció Primària de Gavà) (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00982.x · Cited by 10 · see citing works
Nordstrom, G., Despiégel, N., Marteau, F., Danchenko, N., & Maman, K. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.506371 · Cited by 10 · see citing works
Oliva, J., Brosa, M., Espín, J., Figueras, M., & Trapero‐Bertran, M. (2015) · Revista Española de Salud Pública · doi:10.4321/s1135-57272015000100002 · Cited by 9 · see citing works
Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting
Nuijten, M. J. C., Brignone, M., Marteau, F., den Boer, J. A., & Hoencamp, E. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.006 · Cited by 9 · see citing works
Biesheuvel-Leliefeld, K. E. M., Bosmans, J. E., Dijkstra‐Kersten, S. M. A., Smit, F., Bockting, C., van Schaik, A., van Marwijk, H., & van der Horst, H. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208570 · Cited by 6 · see citing works
The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective
Edwards, R. T. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0748-9 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Time for united action on depression: a Lancet–World Psychiatric Association Commission
Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02141-3 · Cited by 1,104 · see citing works
Shen, J., Begum, N., García, Y. R., Martinón‐Torres, F., Bekkat-Berkani, R., & Meszaros, K. (2022) · BMC Public Health · doi:10.1186/s12889-022-13342-2 · Cited by 75 · see citing works
Jiang, S., Wang, Y., Si, L., Zang, X., Gu, Y., Jiang, Y., Liu, G. G., & Wu, J. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-009777 · Cited by 46 · see citing works
Societal costs and health related quality of life in adult atopic dermatitis
Beretzky, Z., Koszorú, K., Rencz, F., Hajdu, K., Borza, J., Bodai, K., Feifei, X., Szegedi, A., Sárdy, M., & Brodszky, V. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09840-7 · Cited by 27 · see citing works
Rodríguez-Sánchez, B., Aranda-Reneo, I., Oliva, J., & López‐Bastida, J. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s301589 · Cited by 23 · see citing works
Self-citationOn spillovers in economic evaluations: definition, mapping review and research agenda
Mendoza-Jiménez, M. J., van Exel, J. N. A., & Brouwer, W. B. F. (2024) · The European Journal of Health Economics · doi:10.1007/s10198-023-01658-8 · Cited by 19 · see citing works
One-year direct and indirect costs of ischaemic stroke in China
Lv, W., Wang, A., Wang, Q., Wang, R., Xu, Q., Wu, S., Han, Y., Jiang, Y., Lin, J., Jing, J., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-002296 · Cited by 18 · see citing works
Rodríguez-Sánchez, B., Daugbjerg, S. B., Peña-Longobardo, L. M., Oliva, J., Aranda-Reneo, I., Cicchetti, A., & López‐Bastida, J. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01471-9 · Cited by 16 · see citing works
Self-citationGalván, F. H., Liu, H., Brooks, R. A., Chen, Y.-T., & Lepe, R. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268406 · Cited by 14 · see citing works
Asukai, Y., Briggs, A. H., Garrison, L. P., Geisler, B. P., Neumann, P. J., & Ollendorf, D. A. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01088-5 · Cited by 13 · see citing works
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations
Mchenga, M., Vijayasingham, L., RamPrakash, R., & Remme, M. (2024) · Applied Health Economics and Health Policy · doi:10.1007/s40258-024-00930-z · Cited by 12 · see citing works
Yuasa, A., Yonemoto, N., Kamei, K., Murofushi, T., LoPresti, M., Taneja, A., Horgan, J., & Ikeda, S. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02321-z · Cited by 11 · see citing works
Hosseini Jebeli, S. S., Rezapour, A., Hajebi, A., Moradi-Lakeh, M., & Damari, B. (2021) · International Journal of Mental Health Systems · doi:10.1186/s13033-021-00468-w · Cited by 10 · see citing works
Hafner, M., Yerushalmi, E., Andersson, F., & Burtea, T. (2022) · Health Economics · doi:10.1002/hec.4638 · Cited by 9 · see citing works
Crosland, P., Ho, N., Nguyen, K., Tran, K., Hosseini, S. H., Vacher, C., Skinner, A., van Rosmalen, J., Rosenberg, S. P., Iorfino, F., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00459-7 · Cited by 7 · see citing works
Growth and changing landscape of the cost-utility literature: an Australian perspective, 1992-2022
Xia, Q., McPhail, S., Afoakwah, C., Vo, L. K., Lim, M. H. A., Brain, D., Kuwornu, J. P., & Carter, H. E. (2025) · Health Policy · doi:10.1016/j.healthpol.2025.105319 · Cited by 6 · see citing works
Seddik, A. H., Paulissen, J. H. J., Marapin, R. S., Fuhler, S., Johal, S., Rosenlund, M., Dunton, K., Postma, M. J., & Freriks, R. (2025) · Value in Health · doi:10.1016/j.jval.2025.02.009 · Cited by 4 · see citing works
Advancing the economics of prevention: emerging methods and approaches
Grimm, S. E., van Mastrigt, G. A. P. G., & Hiligsmann, M. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2570689 · Cited by 4 · see citing works
Yousefi, M., Mehrabian, A., Brown, A., Butt, F., Donoghue, J., Parr, J., Patel, M., Grove, A., Parsons, J., & Auguste, P. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-04150-z · Cited by 4 · see citing works
Kohrt, B. A., Wahid, S. S., Ottman, K. E., Burgess, A., Viduani, A. C., Martini, T., Benetti, S. P. D. C., Momodu, O., Bohara, J., Neupane, V., et al. (2024) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2024.136 · Cited by 4 · see citing works
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time
Shields, G., Pennington, B., Bullement, A., Wright, S. J., & Elvidge, J. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01116-4 · Cited by 4 · see citing works
The conceptualisation of cardiometabolic disease policy model in the UK
Putri, S., Ciminata, G., Lewsey, J., Jani, B., McMeekin, N., & Geue, C. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11559-y · Cited by 4 · see citing works
Tang, M., Ai, Y., Song, N., Xu, X., Geng, L., Chen, D., Ren, L., Chen, X., Chen, J., Zhang, L., et al. (2024) · Journal of Essential Oil Bearing Plants · doi:10.1080/0972060x.2024.2302410 · Cited by 3 · see citing works
Palmer, A. J., Zhao, T., Taylor, B. V., van der Mei, I. A. F., & Campbell, J. A. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332161 · Cited by 2 · see citing works
Costs of major depression covered / not covered in British Columbia, Canada
Cressman, S., Ghanbarian, S., Edwards, L., Peterson, S., Bunka, M., Hoens, A. M., Riches, L., Austin, J., Vijh, R., McGrail, K. M., et al. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-10474-y · Cited by 2 · see citing works
Bariatric Surgery, Employment, and Productivity Outcomes
Xia, Q., Donovan, T., Diao, J., Yang, X., Jin, X., Lartey, S. T., & Carter, H. E. (2025) · JAMA Surgery · doi:10.1001/jamasurg.2025.3611 · Cited by 1 · see citing works
Tran, P. B., Berete, F., Clercq, B. D., der Heyden, J. V., van Olmen, J., & Willem, L. (2025) · European Journal of Public Health · doi:10.1093/eurpub/ckaf063 · Cited by 1 · see citing works
Measuring and valuing spillover effects in caregivers and families: A scoping review
Dang, T. T. H., Tabinga, A., Beilby, H., Barker, N., Johnson, L. R., Tuffaha, H., Connelly, L. B., & Maguire, A. M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0337253 · Cited by 1 · see citing works
Fatoye, F., Gebrye, T., Nherera, L. M., & Trueman, P. (2024) · Journal of Market Access & Health Policy · doi:10.3390/jmahp12030018 · Cited by 1 · see citing works
Jebeli, S. S. H., Rezapour, A., Hajebi, A., Moradi‐Lakeh, M., & Damari, B. (2021) · Research Square · doi:10.21203/rs.3.rs-52097/v2
Additional file 1 of Costs of major depression covered / not covered in British Columbia, Canada
Cressman, S., Ghanbarian, S., Edwards, L., Peterson, S., Bunka, M., Hoens, A. M., Riches, L., Austin, J., Vijh, R., McGrail, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26656990
Beyond direct medical costs: what we miss when indirect costs are ignored
Religioni, U., Barrios‐Rodríguez, R., Requena, P., & Pakulska, T. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2670957
Lee, H., Kang, H., Paik, J.-W., Jeong, Y., Eum, H., & Lee, H. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2683436
Economic evaluation of deimplementation interventions: a systematic review
Hountongbé, C. L., Guertin, J. R., Gnanou, S., Conombo, B., Tardif, P., Ivers, N. M., Gandhi, R., & Moore, L. (2026) · BMJ Quality & Safety · doi:10.1136/bmjqs-2025-019895
- Authors
- Duevel, J. A., Hasemann, L., Peña-Longobardo, L. M., Rodríguez-Sánchez, B., Aranda-Reneo, I., Oliva-Moreno, J., López-Bastida, J., & Greiner, W.
- Affiliations
- Bielefeld University (DE)
- University of Castilla-La Mancha (ES)
- Camilo José Cela University (ES)
- ORCID
- Venue
- Health Economics Review
- Published
- 2020-09-22
- Volume
- 10
- Issue
- 1
- Pages
- 32-32
- ISSN
- 2191-1991 (ISSN-L)
- PMC
- PMC7510122
- OpenAlex
- W3088578057
- Cited by
- 34
- References
- 101
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 5
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Health Economics Review (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Econstor (Econstor) (submittedVersion, cc-by)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion, cc-by)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- H2020 European Research Council (779312)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Social Sciences › Decision Sciences › Management Science and Operations Research › Evaluation and Performance Assessment
- Keywords
- depression, societal perspective, healthcare payer perspective, cost-utility analysis, cost-effectiveness, cost-effectiveness threshold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
